Walmart Will Cover 250 Prescription Drugs in 2027
The retailer plans to provide no-cost medications and expanded benefits for its 1.6 million U.S. employees starting in 2027.
Updated on Oct. 13, 2026 in Diabetes
Live Poll
Do you believe large employers have a responsibility to expand healthcare benefits for their employees?
Beginning in 2027, Walmart will provide over 250 prescription drugs to its 1.6 million U.S. employees at no cost. The program includes treatments for Type 2 diabetes, migraines, dementia, and cardiovascular conditions.
Why it matters
This initiative provides significant medication access to a vast workforce while reflecting shifting corporate healthcare strategies. It arrives as other employers struggle with the rising costs of GLP-1 medications and specialized care.
The coverage includes diabetes medications like Ozempic and Mounjaro, subject to prior approval. One in ten companies currently offering GLP-1 coverage does not expect to maintain it by 2027.
The players
Walmart
This is a multinational retail corporation that employs 1.6 million people in the United States.
Mayo Clinic
This is a nonprofit academic medical center that will consult on specialized neurological care for eligible Walmart employees.
Cleveland Clinic
This is a multispecialty academic medical center that will provide specialized neurological care consultations for eligible employees.
The details
Workers requiring specialized care for MS, Parkinson's disease, or ALS will gain access to consultations at the Mayo Clinic or Cleveland Clinic. Additionally, the company is introducing 12 weeks of paid leave for employees welcoming newborns into neonatal intensive care.
Timeline
Workers saw a previous increase in insurance premiums in 2026.
Walmart will begin providing 250+ drugs free to employees in 2027.
Health Landscape
This move stands in contrast to the broader industry trend of employers reducing or eliminating coverage for high-cost GLP-1 medications. While eight in ten employers cite specialty drugs as a primary driver for rising healthcare costs, Walmart is expanding access to these treatments for its staff.
Eligible employees will see a direct reduction in out-of-pocket costs for essential medications like Ozempic and Mounjaro. However, patients must navigate a prior approval process to qualify for these benefits.
The takeaway
Employees should begin reviewing their upcoming 2027 benefits packages to determine if their specific prescriptions are included in the new no-cost list. Staying informed about medical necessity requirements will be essential to successfully utilize these specialized care benefits.
Further reading
For more on the challenges of medication access, visit the Diabetes section.
Live Poll
Do you believe large employers have a responsibility to expand healthcare benefits for their employees?
